Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail
NCT01278394
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
29
Enrollment
INDUSTRY
Sponsor class
Conditions
Onychomycosis
Interventions
DRUG:
AN2690 Solution, 5.0%
Sponsor
Pfizer